My Med Pharmcy - Fibrate:- In pharmacology, the fibrates are a class of amphipathic carboxylic acids. They are used for a range of metabolic disorders, mainly hypercholesterolemia (high cholesterol), and are therefore
Update on the use of fibrates: focus on bezafibrate. - Abstract - Europe PMC
Fibrate pharmacogenomics: expanding past the genome | Pharmacogenomics
Atherosclerosis_Lipid_Lowering_Agents
Myopathy with statin–fibrate combination therapy: clinical considerations | Nature Reviews Endocrinology
Arteriosclerosis hardening of the arteries Serum cholesterol above
Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases | SpringerLink
Lowering lipid mechanisms of fenofibrate. Fenifibrate activates PPARα,... | Download Scientific Diagram
Pharmacology of Fibric Acid Derivatives - BioPharma Notes
Fibrate Mechanism of Action - The Center for Cholesterol Management
Dyslipidemia case study
List of fibrates: Uses, common brands, and safety information
Management of Hypertriglyceridemia
Antihyperlipidemics - Fibrates: Nursing Pharmacology | Osmosis
Anti-hyperlipidemic Agents
Management of Hyperlipoprotinaemia - ppt video online download
Pharmacy | Free Full-Text | Treatment Strategy for Dyslipidemia in Cardiovascular Disease Prevention: Focus on Old and New Drugs | HTML
Triglyceride Lowering Drugs - Endotext - NCBI Bookshelf
Is There a Role for Fibrates in the Management of Dyslipidemia in the Metabolic Syndrome? | Arteriosclerosis, Thrombosis, and Vascular Biology
